Inverse association between systemic immune-inflammation index and bone mineral density in postmenopausal women
- 16 February 2021
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (7) , 650-654
Abstract
The aim of the present study was to investigate whether systemic immune-inflammation index (SII) and neutrophil-to-platelet ratio (NLR) were associated with bone mineral density (BMD) in postmenopa... 目的：探讨绝经后妇女全身免疫炎症指数(SII)和中性粒细胞/血小板比值(NLR)与骨密度(BMD)的关系。方法：在这项横断面研究中, 我们招募了413名从未接受过绝经激素治疗的绝经后妇女。用线性回归分析研究SII、NLR与BMD的关系。结果：在绝经后妇女中, SII与BMD呈显著负相关。每四分位数的平均骨密度分别为0.923、0.914、0.900和0.876 g/cm2 (p =.011)...Keywords
Funding Information
- Zhejiang Province Major Science and Technology Program of Medicine and Health (WKJ-ZJ-2010)
This publication has 26 references indexed in Scilit:
- An osteoclastogenesis system, the RANKL/RANK signalling pathway, contributes to aggravated allergic inflammationBritish Journal of Pharmacology, 2019
- The Relationship of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Bone Mineral Density in Korean Postmenopausal WomenChonnam Medical Journal, 2019
- Cytokine profiles in osteoporosis suggest a proresorptive biasMenopause, 2017
- A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 2017
- Bioinformatics analysis of gene expression profiles in B cells of postmenopausal osteoporosis patientsTaiwanese Journal of Obstetrics and Gynecology, 2017
- Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosisMedicine, 2017
- Inflammatory markers and the risk of hip fracture: The women's health initiativeJournal of Bone and Mineral Research, 2012
- Osteoporosis: now and the futureThe Lancet, 2011
- Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosisBone, 2008
- Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.Current Pharmaceutical Design, 2001